Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
1999-07-14
2002-04-30
McDermott, Corrine (Department: 3738)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C128S898000
Reexamination Certificate
active
06379345
ABSTRACT:
INTRODUCTION
1. Technical Field
The field of this invention is vascular disease, particularly vascular diseases characterized by the presence of calcified lesions, e.g. atherosclerosis, and the like.
2. Background of the Invention
The formation of plaques or lesions, (atherosclerotic plaques or lesions) on cardiovascular tissue, such as the inner surface of blood vessels, aortic valves, etc., is a major component of cardiovascular disease. Many atherosclerotic plaques and lesions are characterized by the presence of mineral deposits, i.e. they are calcified. Calcified lesion formation on prosthetic devices is also a problem in current cardiovascular disease treatment protocols. For example, calcification is an important limitation on the useful life expectancy of bioprosthetic valves, and accounts for over sixty percent of the cardiac bioprostheses failures.
A variety of different protocols have been developed for treating cardiovascular diseases associated with the presence of calcified lesions. Such treatment methodologies generally involve mechanical removal or reduction of the lesion, and include: bypass surgery, balloon angioplasty, mechanical debridement, atherectomy, valve replacement, and the like. Despite the plethora of different treatment strategies that have been developed for the treatment of cardiovascular disease, there are disadvantages associated with each technique, such as tissue damage, invasiveness, etc. For example, restenosis is a common complication that results in arteries in which lesions have been mechanically removed.
As such, there is continued interest in the development of new treatment protocols for the removal of vascular calcified lesions from vascular tissue. Of particular interest would be the development of a treatment protocol that is minimally invasive and/or results in minimal tissue damage.
Relevant Literature
U.S. Patents of interest include: U.S. Pat. Nos. 4,445,892; 4,573,966; 4,610,662; 4,636,195; 4,655,746; 4,824,436; 4,911,163; 4,976,733; 5,059,178; 5,090,960; 5,167,628; 5,195,955; 5,222,941; 5,380,284; 5,443,446; and 5,462,529.
SUMMARY OF THE INVENTION
Methods for at least reducing the mineral content of a calcified lesion on vascular tissue are provided. In the subject methods, the local environment of the target lesion is maintained at a subphysiologic pH for a period of time sufficient for the desired amount of demineralization to occur, e.g. by flushing the lesion with a fluid capable of locally increasing the proton concentration in the region of the calcified lesion. As a result, the mineral content of the calcified lesion is reduced. Also provided are kits and systems for practicing the subject methods. The subject invention finds use in a variety of different applications, including the treatment of vascular diseases associated with the presence of calcified lesions.
REFERENCES:
patent: 3651898 (1972-03-01), Caudle et al.
patent: 3855914 (1974-12-01), Nishino et al.
patent: 3860289 (1975-01-01), Learmont
patent: 4022119 (1977-05-01), Karr
patent: 4049519 (1977-09-01), Sloan
patent: 4105253 (1978-08-01), Showalter
patent: 4108764 (1978-08-01), Kaneko et al.
patent: 4250965 (1981-02-01), Wiseman, Jr.
patent: 4358158 (1982-11-01), Showalter
patent: 4445892 (1984-05-01), Hussein et al.
patent: 4573966 (1986-03-01), Weikl et al.
patent: 4610662 (1986-09-01), Weikl et al.
patent: 4636195 (1987-01-01), Wolinsky
patent: 4655746 (1987-04-01), Daniels et al.
patent: 4705517 (1987-11-01), DiPisa, Jr.
patent: 4778006 (1988-10-01), Derowitsch
patent: 4824436 (1989-04-01), Wolinsky
patent: 4850975 (1989-07-01), Furukawa
patent: 4883460 (1989-11-01), Zanetti
patent: 4911163 (1990-03-01), Fina
patent: 4976733 (1990-12-01), Giradot
patent: 5059178 (1991-10-01), Ya
patent: 5069664 (1991-12-01), Guess et al.
patent: 5090960 (1992-02-01), Michael
patent: 5140822 (1992-08-01), Gupta
patent: 5167628 (1992-12-01), Boyles
patent: 5171694 (1992-12-01), Connolly
patent: 5195955 (1993-03-01), Michael
patent: 5222941 (1993-06-01), Michael
patent: 5238845 (1993-08-01), Tancredi et al.
patent: 5380284 (1995-01-01), Michael
patent: 5443446 (1995-08-01), Shturman
patent: 5462529 (1995-10-01), Simpson
patent: 5681507 (1997-10-01), Kazuma
patent: 5702368 (1997-12-01), Stevens et al.
patent: 5736072 (1998-04-01), Satoh
patent: 5758789 (1998-06-01), Shin et al.
patent: 5833650 (1998-11-01), Mir Imran
patent: 6228046 (2001-05-01), Brisken
patent: 97/40756 (1997-11-01), None
patent: 98/25855 (1998-06-01), None
Barrett Thomas
Bozicevic, Field & Francis
Corazon Technologies, Inc.
Field Bret E.
McDermott Corrine
LandOfFree
Methods and devices for reducing the mineral content of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and devices for reducing the mineral content of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and devices for reducing the mineral content of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2898309